Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
about
Smoking cessation and reduction in people with chronic mental illnessSmoking Use and Cessation Among People with Serious Mental IllnessOptogenetic studies of nicotinic contributions to cholinergic signaling in the central nervous systemNicotinic acetylcholine receptor ligands, a patent review (2006-2011)Review of pharmacological treatment in mood disorders and future directions for drug development.Targeting the noradrenergic system for gender-sensitive medication development for tobacco dependenceTwo decades of smoking cessation treatment research on smokers with depression: 1990-2010Molecules and circuits involved in nicotine addiction: The many faces of smokingNeurobiology of chronic mild stress: parallels to major depressionInsights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors: an integrated approach to behaviorally active nicotinic ligands.Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortexVarenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatumEffects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, studyRole for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian miceHow cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways.Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of vareniclineNicotine as a potential neuroprotective agent for Parkinson's disease.Recent developments in novel antidepressants targeting α4β2-nicotinic acetylcholine receptors.Merging old and new perspectives on nicotinic acetylcholine receptorsNew Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine.Nicotine uses neuron-glia communication to enhance hippocampal synaptic transmission and long-term memory.Association of menstrual phase with smoking behavior, mood and menstrual phase-associated symptoms among young Japanese women smokers.Anxiety and depression-Important psychological comorbidities of COPD.Probing the smoking-suicide association: do smoking policy interventions affect suicide risk?Nicotine elicits prolonged calcium signaling along ventral hippocampal axons.Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in ratsNicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression.Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function miceRodent models of treatment-resistant depression.α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties.The effects of prenatal stress on alpha4 beta2 and alpha7 hippocampal nicotinic acetylcholine receptor levels in adult offspringDissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity.Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral statesVarenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivoNeuronal Nicotinic Acetylcholine Receptor Modulators Reduce Sugar Intake.Live Imaging of Nicotine Induced Calcium Signaling and Neurotransmitter Release Along Ventral Hippocampal Axons.
P2860
Q26782639-9DAEA0E0-9A4F-402F-B5A5-E4AC8C92E298Q26785461-2A370ECF-C419-40F9-9A1E-AA117F658024Q26822951-8428BCD6-6297-428C-8B57-1BF2AE6E4D2CQ26824360-0B108A1B-1BA4-45B2-9751-CB49E1BD0609Q26853509-B70F30D0-20C5-43D2-AA97-2ABEBE77748EQ26999258-44A8A108-F1C4-4649-8C44-659051E8DA17Q27003113-DCC0BF83-0943-42E7-A253-8F78FA08AFF0Q27008063-65327D89-7EE2-4CBA-887E-B795BD72E0D9Q27026698-4E7AA031-FEDE-4B05-93C6-284D73C6395EQ27671769-485E8D15-357E-4399-B2E0-C47C9F80C21EQ28293779-1B1C1CD8-E6A6-4746-93F8-5B5633A79730Q28576280-C018AAF6-9F7B-4EC4-9E2D-098AA0118E13Q30443702-24B3A9F8-0FE3-47FA-ADC9-2D70371A1283Q30450052-8645A7F6-7E62-493F-8F3B-08B6E0846899Q30453328-42E5A3A1-5285-4CD9-B45F-396BC8D1F39CQ34157608-82F1FD21-58BC-4ECB-8F7E-3690EBFAAAF0Q34281003-D3D094AE-8FF5-425C-8668-204C9DC63656Q34394190-3AD521CA-B281-43CB-A12C-0A4D65ED7602Q34401492-571A2007-961D-43EE-99BA-DA14516091D1Q34426718-C023B99D-0BC5-45A2-AD47-AE50157F3616Q34490857-A2533062-F5CA-4CF8-910E-1B1BC1D53801Q34604632-48BC4D02-E989-454C-99E7-E114A993028FQ34628577-5A616648-2FF5-49A6-8F48-66960D540D49Q34736733-0BA25BB2-CB31-49BE-A8C1-E8314C1EE755Q35070465-CDF05D05-AA1B-4041-833C-E265E3360289Q35188119-DC835765-92C0-4568-8A60-873B5AF965C2Q35203630-7085D036-9B12-4524-8133-53A0719F9356Q35217714-91EACF54-07A1-4F72-A23A-C19B8B1A17E0Q35264378-2587F131-0191-4FB8-94A5-D276C7F17A9AQ35287782-5C17439B-51B2-4E30-889D-E85DEC5C118EQ35533526-92E564FA-2B2A-4AE2-90EC-19C0B9A707F8Q35580361-4BF9AB2F-50F3-4A52-A111-929979E50249Q35581667-D5E7A9A2-C5CC-4B90-B006-3071E9BD4DC6Q35627758-935CE375-5EA8-4D8C-A389-C1E61231571FQ35699233-482E85C6-6051-4AAA-883F-06F19ABD3A8FQ35738694-4C4F3325-DE20-4069-BCF5-D47AD8427EBBQ35802079-C8166902-A349-47AE-901F-EAA6370565A2Q35972935-DBF769F6-4685-4EBD-AB9F-7F7FD0C9FC05Q35974049-8A14C814-1D62-406A-80B6-391237D4E44DQ35980761-35F90470-8192-4C66-8B7D-92299D8A17D0
P2860
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@ast
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@en
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@nl
type
label
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@ast
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@en
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@nl
prefLabel
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@ast
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@en
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@nl
P2860
P3181
P1476
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis
@en
P2093
Yann S Mineur
P2860
P3181
P356
10.1016/J.TIPS.2010.09.004
P407
P577
2010-12-01T00:00:00Z